NeurOdys Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

NeurOdys Therapeutics General Information

Description

Developer of small molecule therapeutics intended for the modification of disease progression and the improvement of clinical outcomes in patients with Alzheimer's, Parkinson's, and other neurodegenerative disorders. The company's platform identifies and advances novel chemical compounds that target mitochondrial quality control pathways, specifically through the selective inhibition of enzymes like USP30 to restore mitophagy and cellular homeostasis, while integrating rigorous biochemical screening and pharmacodynamic modeling to refine efficacy, enabling the neurodegenerative clinical research sector to develop interventions that address the fundamental biological drivers of neuronal loss.

Contact Information

Website
www.neurodysther.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Amsterdam
  • Netherlands
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • Amsterdam
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeurOdys Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 28-Apr-2026 Completed Out of Business
1. Seed Round 15-Apr-2025 Completed Generating Revenue
To view NeurOdys Therapeutics’s complete valuation and funding history, request access »

Ready to get started?

Request a free trial

NeurOdys Therapeutics FAQs

  • When was NeurOdys Therapeutics founded?

    NeurOdys Therapeutics was founded in 2024.

  • Where is NeurOdys Therapeutics headquartered?

    NeurOdys Therapeutics is headquartered in Amsterdam, Netherlands.

  • What industry is NeurOdys Therapeutics in?

    NeurOdys Therapeutics’s primary industry is Biotechnology.

  • Is NeurOdys Therapeutics a private or public company?

    NeurOdys Therapeutics is a Private company.

  • What is NeurOdys Therapeutics’s current revenue?

    The current revenue for NeurOdys Therapeutics is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process